Armata Pharmaceuticals annual revenue
2013
2014
2020
2021
2022
2023
2024
2025
Armata Pharmaceuticals Revenue Growth & History (ARMP)
Armata Pharmaceuticals reported $4.9M in revenue for fiscal 2025, a decrease of 5.22% from the previous fiscal year.
View full Armata Pharmaceuticals company overviewArmata Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.9M | −$270,000 | −5.22% |
| 2024 | 2024-12-31 | $5.2M | $645,000 | +14.24% |
| 2023 | 2023-12-31 | $4.5M | −$979,000 | −17.77% |
| 2022 | 2022-12-31 | $5.5M | $1.0M | +23.11% |
| 2021 | 2021-12-31 | $4.5M | $3.7M | +443.62% |
| 2020 | 2020-12-31 | $823,000 | — | — |
| 2014 | 2014-12-31 | $409,000 | $328,000 | +404.94% |
| 2013 | 2013-12-31 | $81,000 | — | — |
Armata Pharmaceuticals quarterly revenue
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.5M | $341,000 | +15.72% |
| Q1 2026 | 2026-03-31 | $789,000 | $298,000 | +60.69% |
| Q4 2025 | 2025-12-31 | $1.1M | −$150,000 | −12.15% |
| Q3 2025 | 2025-09-30 | $1.2M | −$1.8M | −61.02% |
| Q2 2025 | 2025-06-30 | $2.2M | $2.2M | — |
| Q1 2025 | 2025-03-31 | $491,000 | −$475,000 | −49.17% |
| Q4 2024 | 2024-12-31 | $1.2M | −$293,000 | −19.18% |
| Q3 2024 | 2024-09-30 | $3.0M | $1.7M | +142.69% |
| Q2 2024 | 2024-06-30 | $0 | −$980,000 | −100.00% |
| Q1 2024 | 2024-03-31 | $966,000 | $170,000 | +21.36% |
| Q4 2023 | 2023-12-31 | $1.5M | $477,000 | +45.39% |
| Q3 2023 | 2023-09-30 | $1.2M | −$113,000 | −8.45% |
| Q2 2023 | 2023-06-30 | $980,000 | −$903,000 | −47.96% |
| Q1 2023 | 2023-03-31 | $796,000 | −$440,000 | −35.60% |
| Q4 2022 | 2022-12-31 | $1.1M | $62,000 | +6.27% |
| Q3 2022 | 2022-09-30 | $1.3M | $87,000 | +6.95% |
| Q2 2022 | 2022-06-30 | $1.9M | $715,000 | +61.22% |
| Q1 2022 | 2022-03-31 | $1.2M | $170,000 | +15.95% |
| Q4 2021 | 2021-12-31 | $989,000 | — | — |
| Q3 2021 | 2021-09-30 | $1.3M | $963,000 | +334.38% |
| Q2 2021 | 2021-06-30 | $1.2M | $1.1M | +3667.74% |
| Q1 2021 | 2021-03-31 | $1.1M | — | — |
| Q3 2020 | 2020-09-30 | $288,000 | — | — |
| Q2 2020 | 2020-06-30 | $31,000 | — | — |
| Q1 2015 | 2015-03-31 | $102,000 | −$2,000 | −1.92% |
| Q4 2014 | 2014-12-31 | $101,000 | $353,000 | +140.08% |
| Q3 2014 | 2014-09-30 | $103,000 | $106,000 | +3533.33% |
| Q2 2014 | 2014-06-30 | $101,000 | −$213,000 | −67.83% |
| Q1 2014 | 2014-03-31 | $104,000 | $82,000 | +372.73% |
| Q4 2013 | 2013-12-31 | −$252,000 | — | — |
| Q3 2013 | 2013-09-30 | −$3,000 | — | — |
| Q2 2013 | 2013-06-30 | $314,000 | — | — |
| Q1 2013 | 2013-03-31 | $22,000 | — | — |
Armata Pharmaceuticals revenue growth trends
Over the last five reported fiscal years, revenue grew from $823,000 to $4.9M, a compound annual growth rate of 42.90%. Armata Pharmaceuticals's latest reported quarter, Q2 2026, generated $2.5M in revenue, an increase of 15.72% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Armata Pharmaceuticals source filings ↗